Publication | Closed Access

Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol

ThrombosisContraceptionVenous DiseaseVenous ThrombosisOral ContraceptivesHormonal ContraceptiveOral ContraceptiveContraceptive Transdermal PatchGynecologyEthinyl EstradiolMedicineWomen's HealthAnesthesiologyReproductive Endocrinology